Best Practice & Research Clinical Endocrinology & Metabolism

Papers
(The TQCC of Best Practice & Research Clinical Endocrinology & Metabolism is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma94
Gut microbiome, prebiotics, intestinal permeability and diabetes complications59
Next-generation therapies for adrenocortical carcinoma56
Menopausal hormone therapy for the management of osteoporosis51
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications51
Gut microbiome and bile acids in obesity-related diseases50
New perspectives for mitotane treatment of adrenocortical carcinoma46
Epidemiology and mortality of Cushing’s syndrome42
Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression42
Gut microbiome and thyroid autoimmunity37
Pheochromocytoma: An approach to diagnosis35
Adrenocortical tumorigenesis: Lessons from genetics34
Genetic underpinnings of asthenozoospermia34
TPO antibody positivity and adverse pregnancy outcomes33
Genetics of ovarian insufficiency and defects of folliculogenesis31
Impact of thyroid disease on fertility and assisted conception30
Cushing's syndrome: Treatment and new therapeutic approaches30
Adrenocortical hyperplasia: A multifaceted disease29
Iodine status and supplementation before, during, and after pregnancy28
Pediatric adrenocortical tumours27
Hormone therapy regimens for managing the menopause and premature ovarian insufficiency27
Genetics of teratozoospermia: Back to the head27
Exposure to endocrine-disrupting compounds such as phthalates and bisphenol A is associated with an increased risk for obesity26
Basics of androgen synthesis and action26
Genetic mutations contributing to non-obstructive azoospermia26
Central diabetes insipidus in children: Diagnosis and management25
Endocrine disruptors and the male reproductive system25
Diagnosis and differential diagnosis of diabetes insipidus: Update25
Endocrine-disrupting chemicals and their effects on puberty25
Metastatic pheochromocytoma and paraganglioma: Management of endocrine manifestations, surgery and ablative procedures, and systemic therapies24
Management of central diabetes insipidus24
Prevalence, diagnosis and outcomes of treatment for primary aldosteronism24
Menopausal hormone therapy and breast cancer risk24
Updates in adrenal steroidogenesis inhibitors for Cushing’s syndrome – A practical guide23
Bone marrow adiposity and the hematopoietic niche: A historical perspective of reciprocity, heterogeneity, and lineage commitment23
Acquired forms of central diabetes insipidus: Mechanisms of disease23
Phthalates, ovarian function and fertility in adulthood22
Role of unilateral adrenalectomy in bilateral adrenal hyperplasias with Cushing’s syndrome22
Immune checkpoint inhibitor-related thyroid dysfunction21
Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism21
The gut microbiota as a versatile immunomodulator in obesity and associated metabolic disorders20
Acquisition of peak bone mass20
Cardiovascular complications of mild autonomous cortisol secretion20
Universal screening for thyroid disease during pregnancy should be performed19
Thyroid hormone system disrupting chemicals19
Surgery for adrenocortical carcinoma: When and how?19
Endocrine-disrupting chemicals and child health19
Gestational diabetes insipidus: Diagnosis and management18
Gut microbiota and metabolic aspects of cancer cachexia18
Indications for treatment of subclinical hypothyroidism and isolated hypothyroxinaemia in pregnancy18
Perinatal exposure to endocrine disrupting chemicals and neurodevelopment: How articles of daily use influence the development of our children18
Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease17
Genetics and epigenetics of autoimmune thyroid diseases: Translational implications17
Management of thyrotoxicosis during pregnancy17
Bone marrow adipose tissue: Role in bone remodeling and energy metabolism17
The spectrum of low-renin hypertension16
Next-generation therapeutic bacteria for treatment of obesity, diabetes, and other endocrine diseases16
New types of localization methods for adrenocorticotropic hormone-dependent Cushing’s syndrome16
Thyroid dysfunction following pregnancy and implications for breastfeeding16
Endocrine disrupting chemicals and bone16
Management of neonates born to mothers with thyroid dysfunction, and points for attention during pregnancy15
Quality of life in Cushing’s syndrome15
Androgens and male sexual function15
Management of adrenal incidentalomas: Working through uncertainty15
Cognitive health after menopause: Does menopausal hormone therapy affect it?15
Genetics of 46,XY gonadal dysgenesis14
Diagnosis and management of premature ovarian insufficiency14
Interpretation of thyroid function tests during pregnancy14
Steroid profiling in the diagnosis of mild and overt Cushing’s syndrome14
Marrow adipogenic lineage precursor: A new cellular component of marrow adipose tissue14
Prenatal exposure to phthalate esters and its impact on child development14
Infertility considerations in klinefelter syndrome: From origin to management13
Genetics of cryptorchidism and testicular regression13
0.017926216125488